Elevated plasma 6‐keto‐prostaglandin F1α in patients in septic shock
Elevated plasma 6‐keto‐prostaglandin F1α in patients in septic shock
复制标题
感染性休克患者血浆 6-酮-前列腺素 F1α 升高
DOI:
--
复制
发表时间:
1985
期刊:
影响因子:
--
通讯作者:
W. C. Wise
中科院分区:
文献类型:
--
作者:
P. Halushka;H. Reines;S. Barrow;I. Blair;C. Dollery;W. Rambo;J. Cook;W. C. Wise
Central venous plasma concentrations of 6-keto-prostaglandin F1α (PGF1α), the stable hydrolysis product of prostacyclin (PGI2, a vasodilator and antiaggregatory metabolite of arachidonic acid), were determined in patients with septic shock. In eight nonsurvivors, the median plasma 6-keto-PGF1α level was 229 pg/ml (range 31 to 21,998), compared to 30 pg/ml (range 22 to 194) in six survivors. In three control patients who were not septic or in shock, the levels were less than 4 pg/ml. This study demonstrates that human septic shock is associated with elevated plasma levels of 6-keto-PGF1α, and raises the possibility that increased PGI2 formation may play a role in human septic shock.